Structure

Physi-Chem Properties

Molecular Weight:  670.42
Volume:  747.718
LogP:  9.402
LogD:  6.403
LogS:  -3.945
# Rotatable Bonds:  14
TPSA:  108.74
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.088
Synthetic Accessibility Score:  5.866
Fsp3:  0.535
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.105
MDCK Permeability:  1.8931103113573045e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.207
Human Intestinal Absorption (HIA):  0.3
20% Bioavailability (F20%):  0.992
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.035
Plasma Protein Binding (PPB):  98.20136260986328%
Volume Distribution (VD):  2.626
Pgp-substrate:  7.364878177642822%

ADMET: Metabolism

CYP1A2-inhibitor:  0.034
CYP1A2-substrate:  0.169
CYP2C19-inhibitor:  0.688
CYP2C19-substrate:  0.393
CYP2C9-inhibitor:  0.782
CYP2C9-substrate:  0.988
CYP2D6-inhibitor:  0.783
CYP2D6-substrate:  0.03
CYP3A4-inhibitor:  0.801
CYP3A4-substrate:  0.694

ADMET: Excretion

Clearance (CL):  14.299
Half-life (T1/2):  0.145

ADMET: Toxicity

hERG Blockers:  0.026
Human Hepatotoxicity (H-HT):  0.819
Drug-inuced Liver Injury (DILI):  0.925
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.944
Maximum Recommended Daily Dose:  0.083
Skin Sensitization:  0.047
Carcinogencity:  0.301
Eye Corrosion:  0.01
Eye Irritation:  0.242
Respiratory Toxicity:  0.938

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC23667

Natural Product ID:  NPC23667
Common Name*:   Guttiferone I
IUPAC Name:   n.a.
Synonyms:   Guttiferone I
Standard InCHIKey:  XIKKSUTXFFVDEF-VOWDTJCUSA-N
Standard InCHI:  InChI=1S/C43H58O6/c1-27(2)13-11-15-31(9)16-18-33-26-42(23-20-29(5)6)38(47)36(37(46)32-17-19-34(44)35(45)25-32)39(48)43(40(42)49,24-21-30(7)8)41(33,10)22-12-14-28(3)4/h13-14,16-17,19-21,25,33,44-45,47H,11-12,15,18,22-24,26H2,1-10H3/b31-16+/t33-,41+,42-,43+/m0/s1
SMILES:  CC(=CCC/C(=C/C[C@H]1C[C@@]2(CC=C(C)C)C(=C(C(=O)c3ccc(c(c3)O)O)C(=O)[C@](CC=C(C)C)(C2=O)[C@]1(C)CCC=C(C)C)O)/C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL445689
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26536 Garcinia humilis Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[15844964]
NPO15264 Garcinia paucinervis Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[20594858]
NPO26536 Garcinia humilis Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO15264 Garcinia paucinervis Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1794 Individual Protein LXR-alpha Homo sapiens IC50 = 3400.0 nM PMID[549949]
NPT1746 Individual Protein LXR-beta Homo sapiens IC50 > 15000.0 nM PMID[549949]
NPT6536 Others Liver X receptor (LXR alpha AND LXR beta) Homo sapiens Ratio IC50 = 5.0 n.a. PMID[549949]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC23667 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC289358
1.0 High Similarity NPC165191
1.0 High Similarity NPC5014
1.0 High Similarity NPC51531
1.0 High Similarity NPC469857
1.0 High Similarity NPC114333
1.0 High Similarity NPC297797
1.0 High Similarity NPC91887
1.0 High Similarity NPC157284
1.0 High Similarity NPC245760
1.0 High Similarity NPC50615
1.0 High Similarity NPC473779
1.0 High Similarity NPC473479
1.0 High Similarity NPC28592
1.0 High Similarity NPC149773
1.0 High Similarity NPC46242
1.0 High Similarity NPC477849
1.0 High Similarity NPC42384
0.9924 High Similarity NPC294330
0.985 High Similarity NPC473527
0.9847 High Similarity NPC7464
0.9704 High Similarity NPC471972
0.9704 High Similarity NPC469855
0.9704 High Similarity NPC471971
0.9704 High Similarity NPC30846
0.9562 High Similarity NPC294679
0.9562 High Similarity NPC8493
0.9562 High Similarity NPC469854
0.9562 High Similarity NPC469856
0.9562 High Similarity NPC145301
0.9562 High Similarity NPC469375
0.9562 High Similarity NPC144247
0.9552 High Similarity NPC469680
0.9552 High Similarity NPC469681
0.9552 High Similarity NPC471974
0.9424 High Similarity NPC471970
0.9313 High Similarity NPC25736
0.9291 High Similarity NPC46549
0.9291 High Similarity NPC264229
0.9291 High Similarity NPC132810
0.9225 High Similarity NPC237441
0.9149 High Similarity NPC273798
0.9028 High Similarity NPC48949
0.8973 High Similarity NPC305710
0.8897 High Similarity NPC138472
0.8897 High Similarity NPC4170
0.8897 High Similarity NPC474715
0.8777 High Similarity NPC118366
0.8777 High Similarity NPC277559
0.8759 High Similarity NPC111845
0.8714 High Similarity NPC230811
0.8676 High Similarity NPC117609
0.8667 High Similarity NPC234175
0.8643 High Similarity NPC49911
0.8633 High Similarity NPC153088
0.8633 High Similarity NPC43353
0.8623 High Similarity NPC294226
0.86 High Similarity NPC471968
0.8592 High Similarity NPC470035
0.8552 High Similarity NPC470038
0.8542 High Similarity NPC199936
0.85 High Similarity NPC258502
0.8472 Intermediate Similarity NPC184935
0.8462 Intermediate Similarity NPC471853
0.8462 Intermediate Similarity NPC476534
0.8456 Intermediate Similarity NPC72667
0.8451 Intermediate Similarity NPC61398
0.8451 Intermediate Similarity NPC416
0.8435 Intermediate Similarity NPC10842
0.8425 Intermediate Similarity NPC258856
0.8382 Intermediate Similarity NPC254492
0.8382 Intermediate Similarity NPC15837
0.838 Intermediate Similarity NPC471152
0.8369 Intermediate Similarity NPC72918
0.8345 Intermediate Similarity NPC141817
0.8345 Intermediate Similarity NPC176030
0.8345 Intermediate Similarity NPC229218
0.8345 Intermediate Similarity NPC192597
0.8345 Intermediate Similarity NPC291078
0.8345 Intermediate Similarity NPC248068
0.8345 Intermediate Similarity NPC169214
0.8333 Intermediate Similarity NPC171460
0.8321 Intermediate Similarity NPC84672
0.8321 Intermediate Similarity NPC69424
0.8321 Intermediate Similarity NPC176130
0.8321 Intermediate Similarity NPC324209
0.8321 Intermediate Similarity NPC150919
0.8321 Intermediate Similarity NPC78364
0.8311 Intermediate Similarity NPC52692
0.831 Intermediate Similarity NPC474311
0.8299 Intermediate Similarity NPC75295
0.8273 Intermediate Similarity NPC108129
0.8267 Intermediate Similarity NPC470037
0.8264 Intermediate Similarity NPC472903
0.8261 Intermediate Similarity NPC96024
0.8252 Intermediate Similarity NPC290030
0.8252 Intermediate Similarity NPC475957
0.8252 Intermediate Similarity NPC147418
0.8252 Intermediate Similarity NPC264022
0.8235 Intermediate Similarity NPC199273
0.8235 Intermediate Similarity NPC15127
0.8228 Intermediate Similarity NPC478060
0.8228 Intermediate Similarity NPC471975
0.8228 Intermediate Similarity NPC470374
0.8228 Intermediate Similarity NPC478059
0.8228 Intermediate Similarity NPC470377
0.8227 Intermediate Similarity NPC477139
0.8227 Intermediate Similarity NPC53896
0.8222 Intermediate Similarity NPC91478
0.8209 Intermediate Similarity NPC236520
0.8209 Intermediate Similarity NPC294361
0.8207 Intermediate Similarity NPC203063
0.8201 Intermediate Similarity NPC117899
0.8201 Intermediate Similarity NPC276238
0.8194 Intermediate Similarity NPC87723
0.8188 Intermediate Similarity NPC471530
0.8182 Intermediate Similarity NPC193358
0.8182 Intermediate Similarity NPC264112
0.8182 Intermediate Similarity NPC194764
0.8182 Intermediate Similarity NPC65005
0.8169 Intermediate Similarity NPC50924
0.8169 Intermediate Similarity NPC202225
0.8163 Intermediate Similarity NPC209085
0.8163 Intermediate Similarity NPC224884
0.8151 Intermediate Similarity NPC472904
0.8148 Intermediate Similarity NPC120545
0.8129 Intermediate Similarity NPC193203
0.8125 Intermediate Similarity NPC53001
0.8121 Intermediate Similarity NPC143685
0.8116 Intermediate Similarity NPC71610
0.8116 Intermediate Similarity NPC3224
0.8112 Intermediate Similarity NPC80035
0.8108 Intermediate Similarity NPC309169
0.8108 Intermediate Similarity NPC196941
0.8106 Intermediate Similarity NPC277394
0.8106 Intermediate Similarity NPC61062
0.8106 Intermediate Similarity NPC299252
0.8099 Intermediate Similarity NPC115458
0.8095 Intermediate Similarity NPC477873
0.8095 Intermediate Similarity NPC469447
0.8095 Intermediate Similarity NPC193555
0.8092 Intermediate Similarity NPC144283
0.8092 Intermediate Similarity NPC35
0.8088 Intermediate Similarity NPC86900
0.8088 Intermediate Similarity NPC282577
0.8085 Intermediate Similarity NPC244699
0.8085 Intermediate Similarity NPC471851
0.8085 Intermediate Similarity NPC17083
0.8085 Intermediate Similarity NPC18798
0.8085 Intermediate Similarity NPC291001
0.8071 Intermediate Similarity NPC303910
0.8069 Intermediate Similarity NPC13715
0.8069 Intermediate Similarity NPC4214
0.8069 Intermediate Similarity NPC206207
0.8058 Intermediate Similarity NPC107672
0.8056 Intermediate Similarity NPC472308
0.8054 Intermediate Similarity NPC160777
0.8054 Intermediate Similarity NPC73416
0.8042 Intermediate Similarity NPC475088
0.8042 Intermediate Similarity NPC293454
0.8041 Intermediate Similarity NPC239608
0.8041 Intermediate Similarity NPC46161
0.8041 Intermediate Similarity NPC238629
0.803 Intermediate Similarity NPC322197
0.8028 Intermediate Similarity NPC175738
0.8028 Intermediate Similarity NPC135801
0.8027 Intermediate Similarity NPC84273
0.8027 Intermediate Similarity NPC472410
0.8025 Intermediate Similarity NPC471969
0.8015 Intermediate Similarity NPC130591
0.8015 Intermediate Similarity NPC234637
0.8015 Intermediate Similarity NPC154696
0.8 Intermediate Similarity NPC476535
0.8 Intermediate Similarity NPC3009
0.8 Intermediate Similarity NPC36868
0.8 Intermediate Similarity NPC229894
0.8 Intermediate Similarity NPC48248
0.7987 Intermediate Similarity NPC79627
0.7987 Intermediate Similarity NPC53520
0.7986 Intermediate Similarity NPC306765
0.7986 Intermediate Similarity NPC283088
0.7986 Intermediate Similarity NPC249272
0.7986 Intermediate Similarity NPC477596
0.7974 Intermediate Similarity NPC124842
0.7973 Intermediate Similarity NPC11314
0.7972 Intermediate Similarity NPC327410
0.7972 Intermediate Similarity NPC78307
0.7961 Intermediate Similarity NPC142654
0.7959 Intermediate Similarity NPC169452
0.7959 Intermediate Similarity NPC181560
0.7958 Intermediate Similarity NPC34070
0.7958 Intermediate Similarity NPC469526
0.7958 Intermediate Similarity NPC243305
0.7956 Intermediate Similarity NPC139171
0.7956 Intermediate Similarity NPC68167
0.7947 Intermediate Similarity NPC476821
0.7945 Intermediate Similarity NPC473622
0.7945 Intermediate Similarity NPC141368
0.7943 Intermediate Similarity NPC99731
0.7943 Intermediate Similarity NPC146647

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC23667 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8276 Intermediate Similarity NPD8166 Discontinued
0.8028 Intermediate Similarity NPD943 Approved
0.8 Intermediate Similarity NPD2932 Approved
0.7868 Intermediate Similarity NPD3019 Approved
0.7786 Intermediate Similarity NPD1470 Approved
0.7697 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD1201 Approved
0.7576 Intermediate Similarity NPD3021 Approved
0.7576 Intermediate Similarity NPD3022 Approved
0.7574 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD3300 Phase 2
0.7536 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD3023 Approved
0.7429 Intermediate Similarity NPD3026 Approved
0.741 Intermediate Similarity NPD3024 Approved
0.741 Intermediate Similarity NPD3025 Approved
0.7324 Intermediate Similarity NPD9269 Phase 2
0.7324 Intermediate Similarity NPD3972 Approved
0.7312 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD9494 Approved
0.729 Intermediate Similarity NPD7390 Discontinued
0.7289 Intermediate Similarity NPD7473 Discontinued
0.7285 Intermediate Similarity NPD5408 Approved
0.7285 Intermediate Similarity NPD5404 Approved
0.7285 Intermediate Similarity NPD5405 Approved
0.7285 Intermediate Similarity NPD5406 Approved
0.7273 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD6663 Approved
0.7205 Intermediate Similarity NPD2801 Approved
0.7192 Intermediate Similarity NPD5736 Approved
0.7179 Intermediate Similarity NPD1511 Approved
0.717 Intermediate Similarity NPD7458 Discontinued
0.7143 Intermediate Similarity NPD1934 Approved
0.7133 Intermediate Similarity NPD230 Phase 1
0.7124 Intermediate Similarity NPD2344 Approved
0.7117 Intermediate Similarity NPD3882 Suspended
0.7111 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD6232 Discontinued
0.7105 Intermediate Similarity NPD2799 Discontinued
0.7097 Intermediate Similarity NPD4628 Phase 3
0.7089 Intermediate Similarity NPD1512 Approved
0.7086 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD3226 Approved
0.7059 Intermediate Similarity NPD2935 Discontinued
0.7055 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD1164 Approved
0.705 Intermediate Similarity NPD5951 Approved
0.7047 Intermediate Similarity NPD3764 Approved
0.7042 Intermediate Similarity NPD9268 Approved
0.7019 Intermediate Similarity NPD7028 Phase 2
0.7014 Intermediate Similarity NPD3092 Approved
0.7013 Intermediate Similarity NPD2346 Discontinued
0.7013 Intermediate Similarity NPD1471 Phase 3
0.7007 Intermediate Similarity NPD2798 Approved
0.6994 Remote Similarity NPD7819 Suspended
0.6987 Remote Similarity NPD7003 Approved
0.6972 Remote Similarity NPD3091 Approved
0.6971 Remote Similarity NPD8434 Phase 2
0.6943 Remote Similarity NPD6190 Approved
0.6943 Remote Similarity NPD2309 Approved
0.6939 Remote Similarity NPD3094 Phase 2
0.6923 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1755 Approved
0.6914 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6912 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6897 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6894 Remote Similarity NPD3020 Approved
0.6887 Remote Similarity NPD8032 Phase 2
0.6883 Remote Similarity NPD1510 Phase 2
0.6875 Remote Similarity NPD6273 Approved
0.6875 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6875 Remote Similarity NPD4059 Approved
0.6875 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6875 Remote Similarity NPD8150 Discontinued
0.6871 Remote Similarity NPD1876 Approved
0.6863 Remote Similarity NPD6651 Approved
0.6863 Remote Similarity NPD1607 Approved
0.6849 Remote Similarity NPD4878 Approved
0.6842 Remote Similarity NPD1240 Approved
0.6842 Remote Similarity NPD3818 Discontinued
0.6842 Remote Similarity NPD3620 Phase 2
0.6842 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6099 Approved
0.6839 Remote Similarity NPD6100 Approved
0.6835 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6824 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6824 Remote Similarity NPD6166 Phase 2
0.6824 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6815 Remote Similarity NPD2800 Approved
0.6813 Remote Similarity NPD4378 Clinical (unspecified phase)
0.681 Remote Similarity NPD4380 Phase 2
0.6807 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5494 Approved
0.6783 Remote Similarity NPD7610 Discontinued
0.6783 Remote Similarity NPD5536 Phase 2
0.6779 Remote Similarity NPD257 Approved
0.6779 Remote Similarity NPD258 Approved
0.6772 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7075 Discontinued
0.6763 Remote Similarity NPD7074 Phase 3
0.6763 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6759 Remote Similarity NPD3095 Discontinued
0.6757 Remote Similarity NPD1283 Approved
0.6752 Remote Similarity NPD970 Clinical (unspecified phase)
0.675 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6748 Remote Similarity NPD3455 Phase 2
0.6747 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6746 Remote Similarity NPD8127 Discontinued
0.6736 Remote Similarity NPD9545 Approved
0.6718 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6714 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6711 Remote Similarity NPD3268 Approved
0.6711 Remote Similarity NPD2313 Discontinued
0.6708 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6599 Discontinued
0.6705 Remote Similarity NPD7054 Approved
0.669 Remote Similarity NPD1651 Approved
0.6688 Remote Similarity NPD447 Suspended
0.6687 Remote Similarity NPD1465 Phase 2
0.6687 Remote Similarity NPD7236 Approved
0.6687 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6686 Remote Similarity NPD5027 Approved
0.6686 Remote Similarity NPD5029 Approved
0.6686 Remote Similarity NPD5031 Approved
0.6686 Remote Similarity NPD7685 Pre-registration
0.6667 Remote Similarity NPD6873 Phase 2
0.6667 Remote Similarity NPD2859 Approved
0.6667 Remote Similarity NPD7472 Approved
0.6667 Remote Similarity NPD2860 Approved
0.6667 Remote Similarity NPD7635 Approved
0.6667 Remote Similarity NPD3750 Approved
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4110 Phase 3
0.6667 Remote Similarity NPD7411 Suspended
0.6648 Remote Similarity NPD4954 Approved
0.6648 Remote Similarity NPD5034 Approved
0.6648 Remote Similarity NPD5032 Approved
0.6648 Remote Similarity NPD5026 Approved
0.6648 Remote Similarity NPD5028 Approved
0.6648 Remote Similarity NPD36 Approved
0.6648 Remote Similarity NPD4955 Approved
0.6647 Remote Similarity NPD5978 Approved
0.6647 Remote Similarity NPD5977 Approved
0.6647 Remote Similarity NPD3817 Phase 2
0.6646 Remote Similarity NPD1549 Phase 2
0.6645 Remote Similarity NPD7095 Approved
0.6645 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6628 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6626 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6623 Remote Similarity NPD826 Approved
0.6623 Remote Similarity NPD825 Approved
0.6619 Remote Similarity NPD74 Approved
0.6619 Remote Similarity NPD9266 Approved
0.6618 Remote Similarity NPD1929 Approved
0.6618 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6618 Remote Similarity NPD1930 Approved
0.661 Remote Similarity NPD5035 Approved
0.6609 Remote Similarity NPD5844 Phase 1
0.6605 Remote Similarity NPD2532 Approved
0.6605 Remote Similarity NPD2533 Approved
0.6605 Remote Similarity NPD2534 Approved
0.6597 Remote Similarity NPD9493 Approved
0.6591 Remote Similarity NPD2933 Approved
0.6591 Remote Similarity NPD5030 Phase 2
0.6591 Remote Similarity NPD7251 Discontinued
0.6591 Remote Similarity NPD2934 Approved
0.6582 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6582 Remote Similarity NPD7266 Discontinued
0.6582 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6573 Remote Similarity NPD2629 Approved
0.6559 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6554 Remote Similarity NPD1281 Approved
0.6554 Remote Similarity NPD7808 Phase 3
0.655 Remote Similarity NPD6959 Discontinued
0.6547 Remote Similarity NPD9267 Approved
0.6547 Remote Similarity NPD9264 Approved
0.6547 Remote Similarity NPD9263 Approved
0.6538 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6534 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6534 Remote Similarity NPD6797 Phase 2
0.6531 Remote Similarity NPD1751 Approved
0.6529 Remote Similarity NPD6234 Discontinued
0.6519 Remote Similarity NPD2796 Approved
0.6519 Remote Similarity NPD2066 Phase 3
0.6519 Remote Similarity NPD6836 Approved
0.6517 Remote Similarity NPD8312 Approved
0.6517 Remote Similarity NPD8313 Approved
0.6514 Remote Similarity NPD1221 Approved
0.6513 Remote Similarity NPD9569 Approved
0.651 Remote Similarity NPD1608 Approved
0.6509 Remote Similarity NPD7768 Phase 2
0.6507 Remote Similarity NPD7009 Phase 2
0.6503 Remote Similarity NPD5283 Phase 1
0.65 Remote Similarity NPD5037 Approved
0.65 Remote Similarity NPD5038 Approved
0.6493 Remote Similarity NPD3495 Discontinued
0.6493 Remote Similarity NPD288 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data